Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.  

The cluster is a national non-profit member and network organization for Norwegian and international companies, research and financial institutions, university hospitals, and organizations – all working in the field of cancer.

The cluster is continuously expanding its member base.  The goal is to become a leading oncology cluster in Europe.

Our Network

Oslo Cancer Cluster strives to create an environment that fosters collaboration and innovation among its members and the community.

To encourage and inspire innovation and “meetings of the minds”, the cluster organizes and co-hosts a series of educational programs featuring distinguished international and national experts, presenting recent advances in oncology.

Members are invited to take an active part in this collaboration, as an organizer and/or participant.

Member Benefits

This following services are provided to members of Oslo Cancer Cluster SA (‘the Cluster’). This information is a part of the membership agreement.

International Network:

The Cluster facilitates participation in national and international conferences.

The Cluster’s secretariat prepares themes and programs for professional meetings and other forums on the basis of input received from Cluster members.

The Cluster’s secretariat offers advice and assistance with establishing direct connections between cluster members and relevant national and international partners.

Wide dissemination of members R&D activities and results:

Member profiles on the Cluster website, with direct links to the members’ own websites.

Logo promotion in national and international forums where the Cluster is represented.

Active showcasing and exposure of participating members at national and international conferences and professional meetings.

Active use of the Cluster’s website and social media to distribute research results and other news from members to general public.

Media consulting and pitching news items from cluster members to the media.

Access to the Cluster’s media contacts.

Contribute during each stage of the innovation process: 

If requested, manage intellectual property rights to be owned by the member, including filing and prosecution activities relating to patents for an agreed compensation.

If requested, negotiate and enter into agreements on member’s behalf with development and commercial partners for an agreed compensation.

Engage and coordinate professional advisors.

Contribute with available capabilities, experiences and a wide global network to help convert research results and new knowledge into innovations.

A politically neutral channel for information about framework conditions of importance to all the members.

Meetings with public authorities in order to influence the health authorities to improve the framework conditions for biotechnology, cancer research and the health system in general.

Courses and competence-raising measures 

Advice and assistance in the preparation of marketing materials, presentations and investor pitches.

Advice on business development, marketing plans and strategy plans.

Advice and assistance in the preparation of articles, articles and letters to the editor.

Please also see the Oslo Cancer Cluster Membership Agreement.